Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The role of empagliflozin in the management of type 2 diabetes by patient profile.

Hedrington MS, Davis SN.

Ther Clin Risk Manag. 2015 May 5;11:739-49. doi: 10.2147/TCRM.S71762. eCollection 2015. Review.

2.
3.

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Whaley JM, Tirmenstein M, Reilly TP, Poucher SM, Saye J, Parikh S, List JF.

Diabetes Metab Syndr Obes. 2012;5:135-48. doi: 10.2147/DMSO.S22503. Epub 2012 Jul 23.

4.

Incretin-based therapies in type 2 diabetes mellitus.

Chia CW, Egan JM.

J Clin Endocrinol Metab. 2008 Oct;93(10):3703-16. doi: 10.1210/jc.2007-2109. Epub 2008 Jul 15. Review.

5.

Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes.

Schneeberger C, Stolk RP, Devries JH, Schneeberger PM, Herings RM, Geerlings SE.

Diabetes Care. 2008 Jul;31(7):1380-5. doi: 10.2337/dc07-2188. Epub 2008 Mar 24.

Supplemental Content

Loading ...
Support Center